Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
about
Updates on the Clinical Trials in Diabetic Macular EdemaFucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisA review of therapies for diabetic macular oedema and rationale for combination therapyVascular Pathophysiology in Hearing Disorders.Corticosteroid therapy for hearing and balance disordersThe effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep.Diabetic macular edema: new concepts in patho-physiology and treatment.Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection.Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.Interleukin-1β and mitochondria damage, and the development of diabetic retinopathy.Effects of maternal treatment with corticosteroids on tight junction protein expression in the cerebral cortex of the ovine fetus with and without exposure to in utero brain ischemia.Therapeutic Options in Refractory Diabetic Macular Oedema.Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literatureContributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Progressive Depletion of Rough Endoplasmic Reticulum in Epithelial Cells of the Small Intestine in Monosodium Glutamate Mice Model of Obesity.Tight junctions and the modulation of barrier function in diseaseCurrent and future approaches in the prevention and treatment of diabetic retinopathy.Ontogeny and the effects of exogenous and endogenous glucocorticoids on tight junction protein expression in ovine cerebral cortices.Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathyAltered transendothelial transport of hormones as a contributor to diabetesThe effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema.Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cellsDexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema[Diabetic retinopathy risk factors].The role of ubiquitination and deubiquitination in the regulation of cell junctions.Intravitreal dexamethasone implants for diabetic macular edema.Impaired vascular endothelial function in patients with diabetic macular edema.Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.Corticosteroids and Anti-Complement Therapy in Retinal Diseases.
P2860
Q26767100-E9A8D7C8-3473-4D97-A459-F7E19597C4F4Q26768638-55178BEE-1A44-463D-B61B-30FB2CA080A3Q27008325-F49D5EF4-3DB9-4A55-A616-C4979AFB48D1Q30427799-E257FC5E-5FAC-457B-AD34-468B1A2CD5C4Q30439597-4264904F-B8C1-4582-BB83-2645E54AD85FQ33534181-BA159506-46A7-4D8D-AA92-135E89D94E72Q33589149-E079EEC7-3829-4D84-BFC9-D8C328324EA6Q33713517-CAB6CC8B-2A6A-4FAA-B430-871F47BC3B10Q35803183-5B69556B-6ECE-497F-820D-7903B3852246Q35822607-FB528FB1-BF85-4573-BCFD-78B1EEA5F990Q35928454-D7838B20-BC76-4BDF-B884-A5AF772E4BDCQ36072853-7E939F0C-DF44-4012-AB95-511EF773B3D0Q36280656-4918921D-CC21-45D6-95E5-F4378F6E8290Q36341458-DAC7B2B9-B99A-4BA5-BB44-996C8D253029Q37084522-D5E28914-1AC1-46D0-B334-DE8AEA227879Q37089093-429969BC-5F9A-4ED6-B84B-37C8E67914E3Q37139446-5D191837-4EB2-417A-B199-868C0077370FQ37221516-B94344EC-25DF-4C15-B426-BC727925828CQ37442699-43E6091C-C78E-4DBA-B43F-DFF9D1BAF119Q38011496-0D333AB2-57BC-4F17-91D7-5C71478157A1Q38213715-5FC9E527-F37D-4EE9-B4C4-B19F7EBB0777Q39248367-F2B62B9A-6171-4A2C-A873-534E17DC2DFBQ39545613-7BDC5089-35D7-42B8-8D14-F21FF4AF0915Q41194130-B764EDAB-D8B6-497D-AF72-32166F3280FFQ41544958-8434A6A8-ACF9-44F2-B328-46455B2C21ECQ41785510-F27B6E55-207E-446E-949F-DE09CB688212Q42039901-0E616EA7-0C70-49D0-9A34-9628E8E572E4Q46573010-FBF1082C-A9A9-42CB-B116-17D53777A7E7Q47592089-15982FA5-7FF0-4F07-91D8-15AFEE6C4B47Q49241521-72E27059-A040-475F-AD1E-2DADCC81CBF2Q49501949-CAD45212-2F8B-4D24-97EC-CD61073B2259Q50095639-659098F8-5F2A-4DD7-9D83-FACFC78933E4Q53619775-945F51E2-E12E-4751-B03A-6D0E554BEC92Q54498160-DEAEE404-0348-43A4-A18B-84408A77AB45
P2860
Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@ast
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@en
type
label
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@ast
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@en
prefLabel
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@ast
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@en
P2860
P1433
P1476
Glucocorticoid regulation of e ...... ents for diabetic retinopathy.
@en
P2093
David A Antonetti
Edward A Felinski
P2860
P304
P356
10.1080/02713680500263598
P577
2005-11-01T00:00:00Z